1. Home
  2. EVTL vs GNLX Comparison

EVTL vs GNLX Comparison

Compare EVTL & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

HOLD

Current Price

$5.55

Market Cap

542.9M

Sector

Industrials

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$4.20

Market Cap

202.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTL
GNLX
Founded
2016
2001
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
542.9M
202.4M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
EVTL
GNLX
Price
$5.55
$4.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$13.20
$19.75
AVG Volume (30 Days)
2.5M
157.5K
Earning Date
08-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.76
$1.99
52 Week High
$15.99
$8.54

Technical Indicators

Market Signals
Indicator
EVTL
GNLX
Relative Strength Index (RSI) 52.77 35.32
Support Level $5.03 $4.00
Resistance Level $5.80 $4.37
Average True Range (ATR) 0.66 0.32
MACD -0.08 -0.01
Stochastic Oscillator 35.20 13.94

Price Performance

Historical Comparison
EVTL
GNLX

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: